Oksana A. Markova, MD, MSc
AO GENERIUM
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Oksana A. Markova, MD, MSc as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:02 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05601999 · Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial InfarctionAO GENERIUM · completed · ST Elevation Myocardial Infarction · study chair
- Ph3NCT05492409 · Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP PatientsAO GENERIUM · completed · Idiopathic Thrombocytopenic Purpura · study chair
- Ph3NCT05220878 · Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITPAO GENERIUM · completed · Idiopathic Thrombocytopenic Purpura · study chair
- Ph2/Ph3NCT05208281 · A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type IIAO GENERIUM · active not recruiting · Mucopolysaccharidosis Type II, Metabolic Diseases · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.